Sign in

CIK 0001785530 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Werewolf Therapeutics, Inc.

Sign in to watch
Ticker
HOWL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
823523180
Phone
617-952-0555
Business address
303 WYMAN STREET, SUITE 300, WALTHAM, MA, 02451
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 10-Q Report Quarterly Report
  9. 8-K Event Results of operations
  10. ARS Other Annual Report to Security Holders
  11. DEFA14A Proxy Proxy Materials
  12. DEF 14A Proxy Proxy Statement
  13. S-8 Other Securities Offered to Employees in Benefit Plans
  14. 10-K Report Annual Report
  15. 8-K Event Results of operations
  16. 8-K Event Material agreement
  17. SC 13G Stake Amended Statement of Ownership
  18. SC 13G Stake Amended Statement of Ownership
  19. SC 13G/A Stake Amended Statement of Ownership
  20. 4 Open-market buy Director bought 1,853,000 shares at $2.21 ($4,095,130)

Page 16 of 23 · 453 filings